Media Centre
Latest press releases
-
Datroway approved in the US for patients with previously treated advanced EGFR-mutated non-small cell lung cancer
-
Alexion data presented at EAN 2025 highlights its leadership and commitment to improving patient outcomes in rare neurological diseases
-
AstraZeneca enters strategic collaboration with CSPC Pharmaceuticals focused on AI-enabled research
-
Fixed-duration Calquence-based regimens approved in EU for patients with chronic lymphocytic leukaemia in the 1st-line setting
-
Enhertu plus pertuzumab reduced the risk of disease progression or death by 44% vs. THP as 1st-line therapy in patients with HER2-positive metastatic breast cancer in DESTINY-Breast09 Phase III trial
Medical Releases
These press releases are specifically for health specialist/medical media and are not for consumer press.
